山东博山制药

Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd., formerly known as Shandong Boshan Pharmaceutical Co., Ltd., is a comprehensive pharmaceutical manufacturer established in 1970 and acquired by Jointown Pharmaceutical Group in 2014. Based in Zibo, Shandong, China, the company specializes in the production of active pharmaceutical ingredients (APIs) and finished dosage forms, including tablets, capsules, creams, liniments, aerosols, and patches. Its product portfolio spans multiple therapeutic areas such as cardiovascular diseases, infectious diseases, oncology, and metabolic disorders, with key products including clotrimazole, isosorbide dinitrate, glibenclamide, and furosemide. The company operates GMP-compliant manufacturing facilities and serves both domestic and international markets.